Oestrogen receptor testing and initiation of adjuvant endocrine therapy in women with ductal carcinoma in situ: a population-based study

Qian Chen, Ian Campbell, Mark Elwood, Alana Cavadino, Phyu Sin Aye, Sandar Tin Tin · 2026

Read Oestrogen receptor testing and initiation of adjuvant endocrine therapy in women with ductal carcinoma in situ: a population-based study by Qian Chen, Ian Campbell, Mark Elwood, Alana Cavadino, Phyu Sin Aye, Sandar Tin Tin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13538164.txt.

Description

Chen and five co-authors studied hormone testing in early breast disease in this paper from twenty twenty-six. Ductal carcinoma in situ is a non-invasive breast lesion. Hormone therapy after surgery may cut later cancer events, but use varies widely. The team linked a national breast register with drug records for over five thousand New Zealand women.

Only about fifteen percent ever had the estrogen receptor test that guides therapy. Testing peaked mid-period, then fell back. One region, Waikato, did most of the testing, tied to trial activity there. Of women with hormone-positive lesions, just a quarter started therapy. Their later event risk looked lowest, though not firmly so. The authors back standardized testing across regions.

Catalog record

CREATORQian Chen, Ian Campbell, Mark Elwood, Alana Cavadino, Phyu Sin Aye, Sandar Tin Tin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13538164

Browse the full library · About the Tower of Babel